Exagen to Announce Second Quarter Financial Results on July 28, 2020
July 16, 2020 10:45 ET
|
Exagen Inc.
SAN DIEGO, July 16, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
Exagen and the Ohio State Innovation Foundation Announce Exclusive License Agreement and Research Collaboration for a Novel, Rule-In, Blood Test to Support the Diagnosis of Fibromyalgia
June 17, 2020 08:25 ET
|
Exagen Inc.
SAN DIEGO, June 17, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
Biogen Presents Positive Phase 2 Cutaneous Lupus Erythematosus (CLE) Data at European E-Congress of Rheumatology (EULAR) 2020
June 04, 2020 07:30 ET
|
Biogen Inc.
Full analysis of the CLE part of the LILAC study reinforces positive top-line results; participants who received BIIB059 (anti-BDCA2) demonstrated statistically significant reduction of disease...
Exagen Inc. Announces Clinical Trial Conducted at Major Academic Center in Distinguishing Type 1 and Type 2 Lupus
June 03, 2020 08:25 ET
|
Exagen Inc.
SAN DIEGO, June 03, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today...
Exagen to Present at the William Blair 40th Annual Growth Stock Conference
May 26, 2020 08:25 ET
|
Exagen Inc.
SAN DIEGO, May 26, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
Equillium Reports First Quarter 2020 Financial Results
May 13, 2020 16:07 ET
|
Equillium
LA JOLLA, Calif., May 13, 2020 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to treat...
Equillium to Present at 2020 RBC Capital Markets Virtual Global Healthcare Conference
May 07, 2020 16:07 ET
|
Equillium
LA JOLLA, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop novel products to...
Exagen to Announce First Quarter Financial Results on May 11, 2020
April 27, 2020 08:25 ET
|
Exagen Inc.
SAN DIEGO, April 27, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
How to Reduce Flares if You Have Lupus
April 21, 2020 14:30 ET
|
American Academy of Dermatology
ROSEMONT, Ill., April 21, 2020 (GLOBE NEWSWIRE) -- Medications for lupus — a long-term autoimmune disease that occurs when a person’s immune system attacks different parts of their body, including...
LUPUS THERAPEUTICS, AFFILIATE OF LUPUS RESEARCH ALLIANCE, DEVELOPING A STUDY FOCUSED ON LUPUS PATIENTS AND COVID-19
April 09, 2020 09:07 ET
|
Lupus Research Alliance
New York, April 09, 2020 (GLOBE NEWSWIRE) -- Lupus Therapeutics, the clinical trial affiliate of the Lupus Research Alliance (LRA), announced today that it is embarking on a clinical study to assess...